Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FKUBF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,512
Award facts
- Contract value 100% obligated
- $30,511.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,511.68 to AmerisourceBergen Drug Corp for the supply of CIMZIA 2x200 mg/ml syringe kits. This award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and other military healthcare systems. The company's extensive portfolio includes brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. This competitive award demonstrates AmerisourceBergen's capability to meet federal pharmaceutical supply requirements and reflects its established role as a primary vendor within the DLA's medical supply chain infrastructure, which is planning to expand pharmaceutical prime vendor capabilities through multiple regional contracts in future procurement cycles.
Quick answers
Who was awarded contract SPE2DB25FKUBF?
SPE2DB25FKUBF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FKUBF worth?
The government has obligated $30,512 on SPE2DB25FKUBF.
Is contract SPE2DB25FKUBF an order under another contract?
Yes. SPE2DB25FKUBF is a delivery order under SPE2DB24D3014, an indefinite delivery contract.
Was contract SPE2DB25FKUBF competed?
The extent of competition for SPE2DB25FKUBF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award